Rueil Malmaison, France

Ioana Kloos

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Pharmacyclics, Inc., Les Laboratoires Servier. Active years: 2014-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ioana Kloos. Retrieved from https://idiyas.com/inventor/ioana-kloos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Ioana Kloos: Revolutionizing Technology in Rueil Malmaison

Introduction: Ioana Kloos is a visionary inventor based in Rueil Malmaison, France, known for her groundbreaking contributions to the field of technology.

Latest Patents: Ioana Kloos holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing her commitment to innovation and sustainability.

Career Highlights: With a career spanning over two decades, Ioana Kloos has worked with leading tech companies to develop cutting-edge solutions that have transformed industries and improved the quality of life for many.

Collaborations: Throughout her career, Ioana Kloos has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and excellence in all her projects.

Conclusion: Ioana Kloos continues to inspire the next generation of inventors with her passion for pushing the boundaries of technology and creating a more sustainable future for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…